Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Approximately 60% of CagriSema-treated participants achieved at least 20% weight loss and 40.4% achieved at least 25% loss
Aetna plans will typically classify drugs into multiple tiers, including generic, preferred brand, non-preferred brand, preferred specialty, non-preferred specialty, and non-formulary
According to data reported in the New England Journal of Medicine [2], higher doses achieved up to 17.5% weight reduction at 24 weeks and over 24% at 48 weeks, alongside consistent HbA1c lowering
In the Phase 2 trial published in the New England Journal of Medicine in 2023, participants on the highest dose of 12mg reported significant reductions in appetite and food intake within the first two weeks
US$ 25.59
US$ 24.42
US$ 25.52
US$ 28.04
US$ 22.46
US$ 22.12
